Measuring quality of life in people living with and beyond cancer in the UK

MOSCHOPOULOU, E, DEANE, J, DUNCAN, M, ISMAIL, SA, MORIARTY, S, SARKER, SJ, WHITE, P, KORSZUN, A, BHUI, K, BOURKE, Liam, CHALDER, T, ELDRIDGE, S, GRIBBEN, J, JONES, L, MCCRONE, P, MORGAN, A, RIDGE, D, ROYLANCE, R, TAYLOR, S and THAHA, M (2021). Measuring quality of life in people living with and beyond cancer in the UK. Supportive Care in Cancer.

[img]
Preview
PDF
Moschopoulou2021_Article_MeasuringQualityOfLifeInPeople.pdf - Published Version
Creative Commons Attribution.

Download (284kB) | Preview
Official URL: https://link.springer.com/article/10.1007/s00520-0...
Open Access URL: https://link.springer.com/content/pdf/10.1007/s005... (Published version)
Link to published version:: https://doi.org/10.1007/s00520-021-06105-z
Related URLs:

    Abstract

    Purpose: The aim of this study was to identify the most appropriate measure of quality of life (QoL) for patients living with and beyond cancer. Methods: One hundred eighty-two people attending cancer clinics in Central London at various stages post-treatment, completed a series of QoL measures: FACT-G, EORTC QLQ-C30 , IOCv2 (positive and negative subscales) and WEMWBS, a wellbeing measure. These measures were chosen as the commonest measures used in previous research. Correlation tests were used to assess the association between scales. Participants were also asked about pertinence and ease of completion. Results: There was a significant positive correlation between the four domain scores of the two health-related QoL measures (.32 ≤ r ≤.72, P <.001), and a significant large negative correlation between these and the negative IOCv2 subscale scores (−.39 ≤ r ≤ −.63, P <.001). There was a significant moderate positive correlation between positive IOCv2 subscale and WEMWBS scores (r =.35, P <.001). However, neither the FACT-G nor the EORTC showed any significant correlation with the positive IOCv2 subscale. Participants rated all measures similarly with regards to pertinence and ease of use. Conclusion: There was little to choose between FACT-G, EORTC, and the negative IOC scales, any of which may be used to measure QoL. However, the two IOCv2 subscales capture unique aspects of QoL compared to the other measures. The IOCv2 can be used to identify those cancer survivors who would benefit from interventions to improve their QoL and to target specific needs thereby providing more holistic and personalised care beyond cancer treatment.

    Item Type: Article
    Uncontrolled Keywords: Assessment; Cancer; Quality of life; Survivorship; Oncology & Carcinogenesis; 11 Medical and Health Sciences; 17 Psychology and Cognitive Sciences
    Identification Number: https://doi.org/10.1007/s00520-021-06105-z
    SWORD Depositor: Symplectic Elements
    Depositing User: Symplectic Elements
    Date Deposited: 04 May 2021 16:41
    Last Modified: 04 May 2021 16:45
    URI: http://shura.shu.ac.uk/id/eprint/28594

    Actions (login required)

    View Item View Item

    Downloads

    Downloads per month over past year

    View more statistics